Filter search criteria using below inputs
Click on magnifying glass icon to search
Company | Country | Symbol |
---|
Time | Volume | TMCI |
---|---|---|
09:32 ET | 1109 | 8.64 |
09:33 ET | 300 | 8.62 |
09:37 ET | 100 | 8.65 |
09:39 ET | 1569 | 8.5 |
09:42 ET | 536 | 8.485 |
09:44 ET | 300 | 8.505 |
09:46 ET | 1200 | 8.54 |
09:48 ET | 100 | 8.565 |
09:53 ET | 100 | 8.5575 |
10:00 ET | 424 | 8.51 |
10:02 ET | 740 | 8.54 |
10:04 ET | 1414 | 8.57 |
10:06 ET | 200 | 8.6 |
10:08 ET | 300 | 8.6 |
10:11 ET | 100 | 8.58 |
10:13 ET | 1000 | 8.59 |
10:15 ET | 1397 | 8.61 |
10:18 ET | 100 | 8.6 |
10:20 ET | 100 | 8.58 |
10:22 ET | 200 | 8.58 |
10:24 ET | 1227 | 8.63 |
10:26 ET | 339 | 8.63 |
Company sortable | Market Cap sortable | P/E Ratio (TTM) sortable | EPS Growth (5yr) sortable |
---|---|---|---|
Treace Medical Concepts Inc | 515.8M | -8.7x | --- |
SI-BONE Inc | 556.5M | -15.1x | --- |
Surmodics Inc | 567.0M | -48.5x | --- |
Semler Scientific Inc | 506.0M | 29.2x | +31.99% |
OrthoPediatrics Corp | 614.8M | -20.9x | --- |
Mesa Laboratories Inc | 632.5M | -2.6x | --- |
Treace Medical Concepts, Inc. is a medical technology company. The Company is focused on advancing the standard of care for the surgical management of bunion and related midfoot deformities. It has patented the Lapiplasty 3D Bunion Correction System a combination of instruments, implants, and surgical methods designed to surgically correct all three planes of the bunion deformity and secure the unstable joint, addressing the root cause of the bunion and helping patients get back to their active lifestyles. It also has Adductoplasty Midfoot Correction System, designed for reproducible surgical correction of the midfoot as well as its Hammertoe PEEK Fixation System designed to address hammertoe, claw toe and mallet toe deformities. The Lapiplasty, Adductoplasty and Hammertoe PEEK Fixation Systems are comprised of single-use implant kits and reusable instrument trays. The Company sells these products to physicians, surgeons, hospitals and ambulatory surgery centers in the United States.
Our Ratings feature offers company-specific research ratings from providers such as First Call, S&P and Argus.
Open a New Account, or Login if you're a client.
You have access to a comprehensive selection of independent research reports from providers such as TD Securities, S&P, INK, and Argus.
Open a New Account, or Login if you're a client.
Market Cap | $515.8M |
---|---|
Revenue (TTM) | $202.9M |
Shares Outstanding | 62.3M |
Dividend Yield | 0.00% |
Annual Dividend Rate | --- |
Ex-Dividend Date | 01-01-01 |
Pay Date | 01-01-01 |
Beta | 0.65 |
EPS | $-0.99 |
Book Value | $2.23 |
P/E Ratio | -8.7x |
Price/Sales (TTM) | 2.5 |
Price/Cash Flow (TTM) | --- |
Operating Margin | -30.69% |
Our Calendar feature allows you to view a wide selection of market and company events, including earnings, dividends, splits, rating changes, guidance, and more. Access past, current and future events in WebBroker.
Open a New Account, or Login if you're a client.